Cargando…
Establishing Good Practices for Exposure–Response Analysis of Clinical Endpoints in Drug Development
This tutorial aims at promoting good practices for exposure–response (E-R) analyses of clinical endpoints in drug development. The focus is on practical aspects of E-R analyses to assist modeling scientists with a process of performing such analyses in a consistent manner across individuals and proj...
Autores principales: | Overgaard, RV, Ingwersen, SH, Tornøe, CW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625861/ https://www.ncbi.nlm.nih.gov/pubmed/26535157 http://dx.doi.org/10.1002/psp4.12015 |
Ejemplares similares
-
Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations
por: Mould, DR, et al.
Publicado: (2015) -
Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure‐Response Analyses Underutilized?
por: Jones, Aksana K., et al.
Publicado: (2019) -
Exposure–Response Modeling of Clinical End Points Using Latent Variable Indirect Response Models
por: Hu, C
Publicado: (2014) -
Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance
por: Byon, W, et al.
Publicado: (2013) -
Enabling Psychiatrists to be Mobile Phone App Developers: Insights Into App Development Methodologies
por: Zhang, Melvyn WB, et al.
Publicado: (2014)